The FDA formally warned three providers of direct-to-consumer DNA tests about medical claims the companies make that the federal watchdog agency hasn’t approved.

The FDA wants the companies; American International Biotechnology Services, Lumigenix Inc and Precision Quality DNA &mdash; to either furnish evidence of device approval or make a case that their products don’t fall under the FDA’s purview.